Next Article in Journal
Efficacy of Kan Jang® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial
Next Article in Special Issue
Therapeutic Strategies to Activate p53
Previous Article in Journal
Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson’s Disease via the Nrf2/Keap1 Pathway
Previous Article in Special Issue
Application of In Silico Filtering and Isothermal Titration Calorimetry for the Discovery of Small Molecule Inhibitors of MDM2
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(8), 1015; https://doi.org/10.3390/ph15081015
Action Date Notes Link
article xml file uploaded 17 August 2022 15:26 CEST Original file -
article xml uploaded. 17 August 2022 15:26 CEST Update https://www.mdpi.com/1424-8247/15/8/1015/xml
article pdf uploaded. 17 August 2022 15:26 CEST Version of Record https://www.mdpi.com/1424-8247/15/8/1015/pdf
article html file updated 17 August 2022 15:27 CEST Original file -
article supplementary file uploaded. 18 August 2022 04:29 CEST - https://www.mdpi.com/1424-8247/15/8/1015#supplementary
article html file updated 18 August 2022 04:30 CEST Update https://www.mdpi.com/1424-8247/15/8/1015/html
Back to TopTop